Isolation, Identification, and Biological Characterization of Phage vB_KpnM_KpVB3 Targeting Carbapenem-Resistant Klebsiella pneumoniae ST11
- PMID: 38561142
- DOI: 10.1016/j.jgar.2024.03.007
Isolation, Identification, and Biological Characterization of Phage vB_KpnM_KpVB3 Targeting Carbapenem-Resistant Klebsiella pneumoniae ST11
Abstract
Objectives: This study aimed to isolate a phage capable of lysing carbapenem-resistant Klebsiella pneumoniae (CRKP) and to analyse its biological characteristics and whole-genome sequence.
Methods: The phage was isolated and purified from the sewage. Transmission electron microscopy (TEM) was employed to observe the bacteriophage's morphology. Phenotypic characterization of the bacteriophages was determined. The genomic information was analysed. Evolutionary relationships were established through comparative genomics, proteomics, and phylogenetic analysis.
Results: The isolation of a virulent phage, named Klebsiella phage vB_KpnM_KpVB3, was notable for forming 6-7 mm transparent circular zones, each surrounded by a distinct halo. The phage had a head diameter of ca. 30 nm and a tail length of ca. 20 nm, being identified as a member of the Myoviridae family and the Caudovirales order. The optimal multiplicity of infection (MOI) was 0.00001, with an incubation period of 20 minutes and a lysis period of 60 minutes, and the number of released phages after lysis was 133±35 PFU/cell. The phage was relatively stable at temperatures ranging from 10°C to 40°C and at pH values ranging from 3 to 11. Its lytic efficiency against CRKP was 30.30%. It has been shown to be able to destroy the biofilm of host bacteria. The bacteriophage genome consists of double-stranded DNA (dsDNA) with a total length of 48,394 base pairs, a GC content of 48.99%, and 78 open reading frames (ORFs).
Conclusion: The study resulted in the isolation vB_KpnM_KpVB3, a phage demonstrating potential therapeutic efficacy against infections caused by CRKP.
Keywords: Biological characteristics; Carbapenem-resistant Klebsiella pneumoniae; Genome; Phage.
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.Ann Clin Microbiol Antimicrob. 2023 Feb 24;22(1):18. doi: 10.1186/s12941-023-00567-1. Ann Clin Microbiol Antimicrob. 2023. PMID: 36829156 Free PMC article.
-
Characterization of Newly Isolated Bacteriophages Targeting Carbapenem-Resistant Klebsiella pneumoniae.J Microbiol. 2024 Dec;62(12):1133-1153. doi: 10.1007/s12275-024-00180-7. Epub 2024 Dec 10. J Microbiol. 2024. PMID: 39656423
-
Isolation and Characterization of vB_kpnM_17-11, a Novel Phage Efficient Against Carbapenem-Resistant Klebsiella pneumoniae.Front Cell Infect Microbiol. 2022 Jul 5;12:897531. doi: 10.3389/fcimb.2022.897531. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35865823 Free PMC article.
-
Bacteriophages of Klebsiella spp., their diversity and potential therapeutic uses.J Med Microbiol. 2020 Feb;69(2):176-194. doi: 10.1099/jmm.0.001141. Epub 2020 Jan 24. J Med Microbiol. 2020. PMID: 31976857 Free PMC article. Review.
-
Phage therapy for Klebsiella pneumoniae: Understanding bacteria-phage interactions for therapeutic innovations.PLoS Pathog. 2025 Apr 8;21(4):e1012971. doi: 10.1371/journal.ppat.1012971. eCollection 2025 Apr. PLoS Pathog. 2025. PMID: 40198880 Free PMC article. Review.
Cited by
-
Analysis of a novel phage as a promising biological agent targeting multidrug resistant Klebsiella pneumoniae.AMB Express. 2025 Mar 5;15(1):37. doi: 10.1186/s13568-025-01846-0. AMB Express. 2025. PMID: 40044971 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous